BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9608292)

  • 1. An assessment of asthmatic patients at four Western Cape community pharmacies.
    Bheekie A; Syce JA; Weinberg EG
    S Afr Med J; 1998 Mar; 88(3):262-6. PubMed ID: 9608292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies.
    Bheekie A; Syce JA; Weinberg EG
    J Clin Pharm Ther; 2001 Aug; 26(4):287-96. PubMed ID: 11493372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic measures: pulmonary function tests. Asthma outcome.
    Enright PL; Lebowitz MD; Cockroft DW
    Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 2):S9-18; discussion S19-20. PubMed ID: 8298772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of asthma in adolescents and young adults: which objective measure is best?
    Ulrik CS; Postma DS; Backer V
    J Asthma; 2005 Sep; 42(7):549-54. PubMed ID: 16169787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthmatic patients' poor awareness of inadequate disease control: a pharmacy-based survey.
    Laforest L; Van Ganse E; Devouassoux G; Osman LM; Brice K; Massol J; Bauguil G; Chamba G
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):146-52. PubMed ID: 17304881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma in elite athletes: how do we manage asthma-like symptoms and asthma in elite athletes?
    Lund TK
    Clin Respir J; 2009 Apr; 3(2):123. PubMed ID: 20298392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies.
    Solidoro P; Braido F; Baratta F; Bagnasco D; Esposito R; Aggeri M; Brusa P
    Panminerva Med; 2013 Mar; 55(1):87-92. PubMed ID: 23474666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
    Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underrecognition and undertreatment of asthma in Cape Town primary school children.
    Ehrlich RI; Jordaan E; du Toit D; Volmink JA; Weinberg E; Zwarenstein M
    S Afr Med J; 1998 Aug; 88(8):986-94. PubMed ID: 9754212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What does adolescent undiagnosed wheeze represent? Findings from the Isle of Wight Cohort.
    Raza A; Kurukulaaratchy RJ; Grundy JD; Clayton CB; Mitchell FA; Roberts G; Ewart S; Sadeghnejad A; Arshad SH
    Eur Respir J; 2012 Sep; 40(3):580-8. PubMed ID: 22267759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of asthma].
    Urso DL; Daniele V; Formaro L; Urso G
    Recenti Prog Med; 2012; 103(7-8):284-7. PubMed ID: 22825384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma control test and peak expiratory flow rate: independent pediatric asthma management tools.
    Chan M; Sitaraman S; Dosanjh A
    J Asthma; 2009 Dec; 46(10):1042-4. PubMed ID: 19995144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS
    Clin Respir J; 2008 Oct; 2(4):247-8. PubMed ID: 20298343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic respiratory symptoms, skin test results, and lung function as predictors of peak flow variability.
    Timonen KL; Nielsen J; Schwartz J; Gotti A; Vondra V; Gratziou C; Giaever P; Roemer W; Brunekreef B
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):776-82. PubMed ID: 9309992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study.
    Mehuys E; Van Bortel L; Annemans L; Remon JP; Van Tongelen I; Van Ganse E; Laforest L; Chamba G; Brusselle G
    Respir Med; 2006 Aug; 100(8):1407-14. PubMed ID: 16386885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma, from childhood to adulthood: a prospective 20-year longitudinal study of a cohort of asthmatics.
    Nunes C; Ladeira S
    J Investig Allergol Clin Immunol; 2002; 12(4):242-9. PubMed ID: 12926183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the adherence to the asthma guidelines by the administration of a questionnaire in community pharmacies].
    Bonanni G; Saso L
    Minerva Med; 2003 Feb; 94(1):29-40. PubMed ID: 12719700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of a nationally coordinated pharmacy-based asthma education intervention.
    Diamond SA; Chapman KR
    Can Respir J; 2001; 8(4):261-5. PubMed ID: 11521142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control.
    Armour CL; Lemay K; Saini B; Reddel HK; Bosnic-Anticevich SZ; Smith LD; Burton D; Song YJ; Alles MC; Stewart K; Emmerton L; Krass I
    J Asthma; 2011 Nov; 48(9):914-22. PubMed ID: 21942306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.